An Activity-Based Biomolecule Labeling Platform for the Imaging of Cells and Tissues Under Oxidative Stress
基于活性的生物分子标记平台,用于氧化应激下细胞和组织的成像
基本信息
- 批准号:10878056
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseBiologicalBiological ModelsCardiovascular DiseasesCell CommunicationCell DeathCell LineCellsChemicalsCoculture TechniquesCollaborationsComplexCoupledDataDetectionDiffuseDiffusionDiseaseEthersExposure toFamilyFluorescence MicroscopyFluorescent ProbesFoundationsGoalsHomeostasisHydrogen PeroxideHypochlorous AcidImageIn VitroLabelMalignant NeoplasmsMapsMeasurementMediatingMetabolicMicrogliaModelingMolecular ProbesMonitorNatureNerve DegenerationNeurodegenerative DisordersNeuronsNoiseOrganismOxidation-ReductionOxidative StressPathologyPhasePhenolsPlayPolymer ChemistryPolymersProcessProductionPropertyProteinsReactionReactive Oxygen SpeciesResearchRoleSamplingSignal TransductionSignaling MoleculeSourceStressSuperoxidesSurfaceSystemTestingTissuesTrainingVisualizationbiological systemscellular imagingcellular targetingdesignexperiencefluorescence imagingfluorophoreimaging platformoxidative damagepolymerizationprogramsquinone methideresponsesmall moleculetool
项目摘要
Project Summary
Reactive oxygen species (ROS) are a family of small-molecules in living systems that serve vital
roles in both signaling and stress. Hydrogen peroxide (H2O2), superoxide (O2•-), and hypochlorous
acid (HOCl), among others, are all examples of ROS that have been traditionally viewed as
sources of oxidative stress and damage. Aberrant ROS production contributes to a multitude of
pathologies such as neurodegeneration, cancer, and cardiovascular disorders. However, ROS
are also critical for maintaining metabolic homeostasis through activation of multiple classes of
proteins. This signal-stress dichotomy, coupled with the small and transient nature of ROS,
presents a challenge when attempting to decode the complex landscape of cellular redox
homeostasis. Fluorescent probes are frequently employed to visualize ROS in living systems
through fluorescence microscopy, however these probes are prone to diffusion after ROS
detection. This leads to inaccurate determination of ROS localization and poor signal-to-noise
responses. As such, there is a need to create probes amenable to the permanent recording of
ROS via fluorescence imaging. We hypothesize that activity-based cell-trappable fluorescent
probes can be used as a platform to gain further understanding of ROS-mediated inter- and intra-
cellular signaling. We propose three specific aims to test this hypothesis. First, we will synthesize
fluorophores caged with activity-based triggers and proximal fluoromethyl groups to serve as
latent equivalents of quinone methide upon ROS sensing. ROS responsive uncaging will allow
for the fluorescent labeling of adjacent biomolecules. Second, we will apply our probes across
multiple model live cell lines to monitor ROS fluxes. We will also map cell-to-cell communication
mediated by ROS using microglia-neuron co-culture as a biological model. This system will allow
us to probe transcellular redox signaling as microglia can be selectively activated in the presence
of neurons thereby dispatching H2O2 to nearby neurons. The third aim involves developing a
fluorescent polymer amplification strategy to increase signal-to-noise responses of tandem
activity-based sensing/labeling probes and will primarily be carried out in the R00 phase. Small-
molecule polymer initiators will be caged in a similar manner to the previously described
fluorescent probes. After ROS sensing and biomolecule labeling, polymerization will be performed
to generate fluorescent polymers from biomolecule surfaces thus enabling signal amplification
and visualization. This strategy will be carried over into live cell lines described above. This
research fits into the applicant’s goal of establishing a program which uses polymer chemistry to
probe fundamental questions in biological systems.
项目摘要
活性氧(ROS)是生命系统中的一个小分子家族,
在信号和压力中的作用。过氧化氢(H2 O2)、超氧化物(O2·-)和次氯酸
酸(HOCl)等都是传统上被视为ROS的例子。
氧化应激和损伤的来源。异常的ROS产生导致了许多
病理学如神经变性、癌症和心血管疾病。然而,ROS
对于通过激活多种类型的代谢酶来维持代谢稳态也是至关重要的。
proteins.这种信号-应激二分法,加上ROS的小而短暂的性质,
当试图解码细胞氧化还原的复杂景观时,
体内平衡荧光探针经常被用来观察生命系统中的活性氧
通过荧光显微镜,然而,这些探针在ROS后易于扩散,
侦测这导致ROS定位的不准确测定和差的信噪比
应答因此,需要创建适合于永久记录的探针,
ROS通过荧光成像。我们假设基于活性的细胞可捕获荧光
探针可用作进一步了解ROS介导的细胞间和细胞内
细胞信号我们提出了三个具体目标来检验这一假设。首先,我们将综合
用基于活性的触发剂和近端氟甲基笼住的荧光团,
潜在当量的醌甲基化物的ROS传感。ROS响应性撑开将允许
用于相邻生物分子的荧光标记。第二,我们将把我们的探测器应用于
多个模型活细胞系以监测ROS通量。我们还将绘制细胞间的通讯
使用小胶质细胞-神经元共培养物作为生物模型,该系统将允许
我们探测跨细胞氧化还原信号,因为小胶质细胞可以选择性地激活,
从而将H2 O2发送到附近的神经元。第三个目标是发展一个
荧光聚合物扩增策略,以增加串联的信噪比响应
基于活动的传感/标记探针,主要将在R 00阶段进行。小-
分子聚合物引发剂将以与前述类似的方式被笼化
荧光探针。在ROS感测和生物分子标记之后,将进行聚合
从生物分子表面产生荧光聚合物,
和可视化。该策略将延续到上述活细胞系中。这
研究符合申请人的目标,即建立一个使用聚合物化学的程序,
探索生物系统中的基本问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marco Messina其他文献
Marco Messina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marco Messina', 18)}}的其他基金
An Activity-Based Biomolecule Labeling Platform for the Imaging of Cells and Tissues Under Oxidative Stress
基于活性的生物分子标记平台,用于氧化应激下细胞和组织的成像
- 批准号:
10283664 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
An Activity-Based Biomolecule Labeling Platform for the Imaging of Cells and Tissues Under Oxidative Stress
基于活性的生物分子标记平台,用于氧化应激下细胞和组织的成像
- 批准号:
10468191 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 24.9万 - 项目类别:














{{item.name}}会员




